Though the processes of care for emergency coronary artery bypass graft (CABG) surgery were altered by the COVID-19 pandemic, patient mortality did not change for COVID-19-negative patients; however, COVID-19 positive patients did have significantly higher mortality as well as infectious complications, finds this study presented May 6 at the American Association for Thoracic Surgery 103rd Annual Meeting in Los Angeles.
A total of 16,757 patients (16,262 COVID-19 negative; 125 COVID-19 positive less than 2 weeks before surgery; 370 COVID-19 positive more than 2 weeks before surgery) in the National COVID Cohort Collaborative and 546 pre-COVID-19 control patients in the National Surgical Quality Improvement Program database were included in the analysis.
Among the findings:
The researchers concluded that equivalent mortality in COVID-19 negative patients and pre-COVID-19 patients indicates that COVID-19 associated changes in processes of care did not affect CABG outcomes. Research into optimal timing of CABG surgery after COVID-19 positivity is warranted.Read More >>